Human–Machine Boundary Management

1. Hypothesis

A transparent, safety-bounded and person-centred approach to human–machine boundary management, combining validated measurement, informed consent, privacy and security controls, human oversight and longitudinal monitoring, will improve benefit–risk outcomes compared with opaque or technology-centred approaches.

2. Experiment design

Design: prospective mixed-method augmentation study with functional baseline, intervention comparison and long-term adaptation follow-up focused on Human–Machine Boundary Management Methods: controlled performance testing; longitudinal outcome measurement; human-factors evaluation; equity analysis; dependency assessment; user interviews; ethics and policy review; expert and affected-user review; reproducibility testing; methods adapted specifically to Human–Machine Boundary Management Independent variables: technology type; exposure or intervention intensity; duration; assurance controls; human oversight; user characteristics; operating context Dependent variables: functional outcome; biological or neural safety; user agency; privacy; reliability; recovery; subtopic-specific outcome for clear control, responsibility and identity boundaries in integrated human–machine systems Confounders: age; health; disability; medication; prior experience; baseline physiology; environment; device quality; clinician or operator expertise; socioeconomic access Measures: functional gain; quality of life; fatigue; dependency; reversibility; access equity; adverse events; identity continuity; user agency; validated subtopic measures for clear control, responsibility and identity boundaries in integrated human–machine systems; subgroup effects; false-positive and false-negative rates; user-reported burden Success criteria: Statistically and clinically or practically meaningful benefit; acceptable adverse-event profile; preserved agency and privacy; no disproportionate subgroup harm; reproducible performance; explicit safety limits; effective recovery and human escalation. Failure conditions: No meaningful benefit; biological, neural, psychological, privacy or rights harm exceeds benefit; performance fails outside narrow conditions; unsafe dependency emerges; consent or refusal is compromised; incidents cannot be detected, reversed or remediated.

3. Seed result / current evidence

DEFENSIBLE SEED RESULT — NON-EMPIRICAL. The current evidence supports Human–Machine Boundary Management as a testable research proposition. Problem basis: Augmentation can improve function and participation but may create dependency, inequity, coercion, new safety risks and contested boundaries between therapy and enhancement. The specific unresolved issue is clear control, responsibility and identity boundaries in integrated human–machine systems. Directional expectation: If supported, the proposed approach should improve functional outcome; biological or neural safety; user agency; privacy; reliability; recovery; subtopic-specific outcome for clear control, responsibility and identity boundaries in integrated human–machine systems while reducing adverse effects, misuse, exclusion, dependency and recovery time. Proposed observations: functional gain; quality of life; fatigue; dependency; reversibility; access equity; adverse events; identity continuity; user agency; validated subtopic measures for clear control, responsibility and identity boundaries in integrated human–machine systems; subgroup effects; false-positive and false-negative rates; user-reported burden. Seed data profile: Evidence Strength 10/100; Confidence 25/100; Maturity 20/100; Overall Health 35/100; Novelty 80/100; Strategic Importance 95/100. Evidence boundary: No validated results yet.; experiments 0, studies 0, participants 0. This is suitable for protocol formation and baseline comparison, not as a finding of effect.

4. Seed conclusion

DEFENSIBLE SEED CONCLUSION — PROVISIONAL. Human–Machine Boundary Management warrants structured testing because the CSV identifies a defined problem, falsifiable hypothesis, measurable outcomes and relevant literature foundations. The present position is that “A transparent, safety-bounded and person-centred approach to human–machine boundary management, combining validated measurement, informed consent, privacy and security controls, human oversight and longitudinal monitoring, will improve benefit–risk outcomes compared with opaque or technology-centred approaches.” is plausible and decision-relevant, but unvalidated. Proceed to controlled testing against the stated success and failure conditions. Confirm, narrow or reject this seed after effect sizes, uncertainty, subgroup outcomes, adverse effects, persistence and handback performance are observed.

Prior-art search performed before starting

PRIOR-ART SEED BASELINE — PARTIAL. The CSV records these literature domains: Neuroscience; neurotechnology; physiology; medical-device safety; rehabilitation; cybersecurity; bioethics; human rights; literature specific to Human–Machine Boundary Management. It also records: WHO assistive technology — https://www.who.int/health-topics/assistive-technology; UNESCO bioethics — https://www.unesco.org/; NIH rehabilitation research — https://www.nih.gov/; OECD responsible innovation resources — https://www.oecd.org/. Evidence register status: “Seeded; authoritative source register initiated; empirical evidence not yet ingested”. This is defensible as a starting prior-art inventory, but not as proof of a completed systematic search because search dates, databases, exact queries, reviewer, result counts, screening decisions, claim mapping and a replayable receipt are absent.

Prior-art material named: Existing literature: Neuroscience; neurotechnology; physiology; medical-device safety; rehabilitation; cybersecurity; bioethics; human rights; literature specific to Human–Machine Boundary Management. References: WHO assistive technology — https://www.who.int/health-topics/assistive-technology; UNESCO bioethics — https://www.unesco.org/; NIH rehabilitation research — https://www.nih.gov/; OECD responsible innovation resources — https://www.oecd.org/

Critical gap / next action

Create and attach a dated prior-art search log; lock the protocol; execute the proposed study; link raw data and analysis; then replace the results and conclusion placeholders with evidence-bounded findings.